Effect of hypoxic modification with Nimorazole
Endpoint
Loco- regional
failure
Dead of
disease
Relative Risk Reduction
26%
27%
Absolute Risk Reduction
16%
12%
Number of patients
needed to treat
(to achive benefit)
6